Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology

Atopic dermatitis (AD) is a condition frequently encountered in medical practices across the country. More than 60% of children with AD are at risk to develop allergic rhinitis or asthma (the atopic march). Patients with AD have a unique predisposition to colonization or infection by Staphylococcus...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowicki, Roman, Trzeciak, Magdalena, Wilkowska, Aleksandra, Sokołowska-Wojdyło, Małgorzata, Ługowska-Umer, Hanna, Barańska-Rybak, Wioletta, Kaczmarski, Maciej, Kowalewski, Cezary, Kruszewski, Jerzy, Maj, Joanna, Silny, Wojciech, Śpiewak, Radosław, Petranyuk, Andriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Special Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565838/
https://www.ncbi.nlm.nih.gov/pubmed/26366146
http://dx.doi.org/10.5114/pdia.2015.53319
Descripción
Sumario:Atopic dermatitis (AD) is a condition frequently encountered in medical practices across the country. More than 60% of children with AD are at risk to develop allergic rhinitis or asthma (the atopic march). Patients with AD have a unique predisposition to colonization or infection by Staphylococcus aureus. Treatments for AD need to rapidly control symptoms of the disease, improve quality of life and prevent exacerbations. Given the chronic and relapsing nature of the disease, therapies need to encourage good compliance and be well tolerated.

Ejemplares similares